Share this @internewscast.com
Stanley Erck is not featured on the Wikipedia but his professional boundaries can be found on online media platforms.
Stanley Erck is a CEO and president of the biotechnology company Novavax.
The company precisely works on the discovery, development, and commercialization of vaccines that are used to prevent from the dangerous infectious diseases. One of them being Covid-19 vaccines.
Now the company is reported to have produced a vaccine named Covavax with 90.4% efficacy on the ongoing Omicron variant.
With the successful data presented after the trials, the company will be producing over 1 billion vaccines. Meanwhile, UK, USA, and Europe have already booked orders of 60 million, 110 million, and up to 200 million doses respectively.
Erck stated in an interview that Novavax is a protein-based vaccine which should be given to the people 21 days apart.
“It’s probably going to be next week,” @Novavax CEO Stanley Erck says about filing with the FDA for COVID-19 vaccine authorization in the U.S. “I’m sticking with the claim that we’ll be doing this by the end of the year.” Full interview: pic.twitter.com/pGch6FYdwr
— Yahoo Finance (@YahooFinance) December 23, 2021
Stanley Erck Wikipedia Details
Stanley Erck is an American entrepreneur who is serving as a CEO, President, and Director of Covavax.
In addition, he has been working as a Board of Directors for BioCryst Pharmaceuticals for over 13 years and MaxCyte Inc. for 15 years.
Established himself as profound and dependable leader, Erck started out his professional journey as the vice-president for Integrated Genetics Inc. which was merged with Genzyme Genetics in 1983.
Later, he became the CEO of Procept for 10 years before signing with PHT Corporation in 1999. After serving there as a CEO for a year, Erck became CEO for Iomai Corporation and worked till 2008.
Talking about his academic background, Stanley earned his undergraduate degree from the University of Illinois and Master’s in Business administration from the University of Chicago Booth School of Business.
Stanley Erck Net Worth
Stanley Erck has an estimated net worth of $11.8 million.
He receives a paycheck of $2.4 million on an annual basis for serving Novavax as President, CEO, and Director.
Erck owns near 7k units of Novavax stock which is worth of $5.7 million. During his last 13 years, he has sold Novavax stock of over $3.5 million.
Further, his service to several companies for near 4 decades has earned him hefty sum and is a respected millionaire.
Novavax CEO Stanley Erck today addressed @BIOConvention and discussed why transferring intellectual property doesn’t get vaccines to the world faster. Get the recap on the live blog: https://t.co/IAi9Cwa1Z0 #BIODIGITAL pic.twitter.com/4oI4e6FYuC
— Novavax (@Novavax) June 14, 2021
Stanley Erck Age And Wife
Stanley Erck, 72, could be a married man but the detail of his wife is left unknown at the moment.
Currently enjoying his early-70s, Erck keeps his personal life a secret and has been tight-lipped regarding the info of his marital life.
However, given his age, Stanley Erck must have enjoyed his adult years being a lovely husband and a father.
Source: This post first appeared on XYZ
